Rosaria Volpini Selected Research

Rosaria Volpini Research Topics

Disease

8	Parkinson Disease (Parkinson's Disease) 01/2022 - 04/2005
7	Neoplasms (Cancer) 06/2022 - 02/2007
6	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2022 - 01/2007
5	Asthma (Bronchial Asthma) 06/2022 - 01/2003
4	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2003
4	Inflammation (Inflammations) 04/2019 - 01/2015
3	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 06/2022 - 01/2018
3	Neuroinflammatory Diseases 01/2022 - 01/2020
3	Pain (Aches) 01/2020 - 07/2013
3	Ischemia 01/2019 - 09/2007
3	Central Nervous System Diseases (CNS Diseases) 01/2016 - 03/2007
3	Astrocytoma (Pilocytic Astrocytoma) 07/2011 - 03/2005
2	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 07/2018
2	Hypersensitivity (Allergy) 01/2020 - 03/2010
2	Bulimia (Binge Eating) 12/2019 - 09/2012
2	Neuralgia (Stump Neuralgia) 01/2019 - 07/2013
2	Neuroblastoma 01/2019 - 03/2005
2	Chronic Pain 01/2017 - 07/2013
1	Atherosclerosis 06/2022
1	Type 2 Diabetes Mellitus (MODY) 06/2022
1	Nervous System Diseases (Neurological Disorders) 01/2022
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2022
1	Multiple Sclerosis 01/2022
1	Insulin Resistance 12/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2021
1	Dementia (Dementias) 01/2021
1	Colitis 01/2020
1	Chronic Cough 12/2019
1	Stroke (Strokes) 01/2019
1	Brain Ischemia (Cerebral Ischemia) 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 07/2018
1	Colorectal Neoplasms (Colorectal Cancer) 07/2018
1	Intestinal Diseases (Diseases, Intestinal) 01/2018
1	Disease Progression 08/2015
1	Endocrine System Diseases (Endocrine Diseases) 01/2015
1	Cancer Pain 01/2015
1	Infarction (Infarctions) 08/2014
1	Migraine Disorders (Migraine) 07/2013
1	Alcoholism (Alcohol Abuse) 02/2012
1	Substance-Related Disorders (Drug Abuse) 02/2012
1	Dry Eye Syndromes (Dry Eye Syndrome) 11/2010
1	Rheumatoid Arthritis 11/2010
1	Pathologic Processes 11/2010
1	Tremor (Tremors) 03/2010

Drug/Important Bio-Agent (IBA)

13	Purinergic P1 Receptors (Adenosine Receptor)IBA 06/2022 - 01/2007
8	Adenosine (Adenocard)FDA LinkGeneric 06/2022 - 04/2005
7	LigandsIBA 01/2022 - 01/2007
5	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 12/2019 - 04/2005
4	Purinergic P1 Receptor AntagonistsIBA 01/2022 - 03/2007
3	CytokinesIBA 02/2021 - 01/2020
3	Adenine FDA LinkGeneric 02/2021 - 03/2005
2	Adenosine A1 ReceptorIBA 12/2021 - 01/2019
2	Protein Isoforms (Isoforms)IBA 09/2020 - 03/2010
2	AntioxidantsIBA 01/2020 - 01/2019
2	Purinergic P2X3 ReceptorsIBA 04/2019 - 01/2017
2	Oxygen (Dioxygen)IBA 01/2019 - 06/2011
2	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 06/2011
2	Glutamic Acid (Glutamate)FDA Link 01/2019 - 08/2015
2	Pharmaceutical PreparationsIBA 07/2018 - 02/2007
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 07/2011 - 03/2010
2	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 11/2010 - 01/2009
2	8-ethoxy- 9-ethyladenineIBA 03/2010 - 04/2005
2	Adenosine A2 Receptor AntagonistsIBA 06/2009 - 04/2005
2	9-ethyladenineIBA 06/2009 - 04/2005
1	NucleosidesIBA 04/2022
1	Cytostatic AgentsIBA 01/2022
1	N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosineIBA 01/2022
1	Casein Kinases (Casein Kinase)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	istradefyllineIBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2021
1	InterleukinsIBA 02/2021
1	InterferonsIBA 02/2021
1	2'-deoxyadenosineIBA 02/2021
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2021
1	IsoenzymesIBA 09/2020
1	hydroxide ionIBA 09/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020
1	2,4-dinitrofluorobenzene sulfonic acidIBA 01/2020
1	2,4-dinitrobenzeneIBA 01/2020
1	Sulfonic AcidsIBA 01/2020
1	Neuroprotective AgentsIBA 01/2020
1	Adenosine A3 ReceptorIBA 01/2020
1	PyridinesIBA 12/2019
1	BLU-5937IBA 12/2019
1	GefapixantIBA 12/2019
1	CalciumIBA 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2018
1	Antineoplastic Agents (Antineoplastics)IBA 07/2018
1	purineIBA 01/2018
1	Drug CombinationsIBA 08/2015
1	Levodopa (L Dopa)FDA LinkGeneric 08/2015
1	2- (3- hydroxy- 3- phenyl- 1- propyn- 1- yl)- 5'- N- ethylcarboxamidoadenosineIBA 08/2014
1	2- (4- (2- carboxyethyl)phenethylamino)- 5'- N- ethylcarboxamidoadenosineIBA 09/2012
1	Ethanol (Ethyl Alcohol)IBA 02/2012
1	Purinergic P2 Receptors (ADP Receptor)IBA 06/2011
1	Mitogen-Activated Protein KinasesIBA 06/2011
1	Rhodopsin (Visual Purple)IBA 03/2010
1	Tacrine (Cognex)FDA Link 03/2010

Therapy/Procedure

7	Therapeutics 01/2022 - 11/2010